Cerebrovascular reserve testing via transcranial Doppler ultrasound useful in identifying asymptomatic patients with carotid artery stenosis at risk for stroke.
Cerebrovascular reserve (CVR) testing can help identify asymptomatic patients with carotid artery stenosis who are most likely to benefit from revascularization, according to an article published online in the journal Radiology.
Researchers from Weill Cornell Medical College in New York, NY, sought to project and compare the lifetime health benefits, healthcare costs and incremental cost-effectiveness of stroke prevention strategies among patients who had carotid artery stenosis but were also asymptomatic.
For the study, the researchers used transcranial Doppler (TCD) sonography and constructed a mathematical model that allowed them to make hypothetical comparisons among three different approaches: CVR testing, immediate revascularization with carotid endarterectomy and medical therapy-based management with subsequent revascularization only for patients whose stenosis worsened.
“A decision analytic model was developed to project lifetime quality-adjusted life years (QALYs) and costs for asymptomatic patients with carotid stenosis with 70 percent to 89 percent carotid luminal narrowing at presentation,” the authors wrote.
The results showed that the medical therapy-based strategy was associated with the lowest lifetime costs and the fewest revascularizations. However, this strategy also resulted in the lowest life expectancy and lifetime quality-adjusted years.
“The study results show that imaging can be a cost-effective tool to stratify patients by risk of stroke and help sort patients into invasive, expensive interventions and less invasive options,” co-author Ankur Pandya, PhD, assistant professor of healthcare policy and research and public health in radiology at Weill Cornell Medical College, said in a release. “There are complications and costs associated with these revascularization procedures, and they are often done without knowing if the risks and costs are worth the benefits.”
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.